Fri, Oct 9 11:59 PM

Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials

Bloomberg Markets•Fri, Oct 9, 2026, 10:06 PM•2 min read

Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.

Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-10-09/bambusa-therapeutics-files-for-ipo-to-fund-eczema-drug-trials)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Bloomberg Markets ↗

#finance #bambusa #therapeutics #fund #eczema #trials #files #ipo #drug

More Headlines

HealthHacker News• 6m ago

Clinical trial of a prion disease drug candidate begins enrolling participants

1 points, 0 comments on Hacker News

FinanceInvesting.com• 28m ago

Immunovant chief legal officer Van Tuyl sells $42,543 in stock

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 28m ago

Pacira BioSciences senior vice president Lauren Riker sells $217,920 in stock

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 28m ago

SailPoint chief accounting officer Mitra sells $23,360 in shares

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 29m ago

Trump says Russia to supply diesel to US and global markets

Developing story — details emerging. Check the source link for the latest updates.

FinanceCBS News• 35m ago

Trump launches new investigation into Fed Gov. Lisa Cook

President Trump says a committee will investigate Federal Reserve Gov. Lisa Cook and determine whether there is cause to remove her from the board. CBS News homeland security correspondent Nicole Sganga has the details.